← FDA DRUG APPROVALS

FDA ANDA · ANDA217535

SODIUM CHLORIDE 0.9%

Sponsor: NEXUS

APPLICATION
ANDA217535
TYPE
ANDA
ORIGINAL APPROVAL
2023-08-23
LATEST ACTION
2023-08-23
ROUTE
INJECTION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

SODIUM CHLORIDE 0.9%Prescription
SODIUM CHLORIDE 90MG/10ML (9MG/ML) · SOLUTION · INJECTION
SODIUM CHLORIDE 0.9%Prescription
SODIUM CHLORIDE 180MG/20ML (9MG/ML) · SOLUTION · INJECTION

Approval history

2023-08-23UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →